InsidersTradesSigma
Explore the full management transaction log of SCICLONE PHARMACEUTICALS INC, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 6 January 2016 (Levée d'options). Among the most active insiders: Blobel Friedhelm. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
SCICLONE PHARMACEUTICALS INC is a pharmaceutical company focused on the development and commercialization of innovative therapeutic products. It is listed on NASDAQ under the ticker SCIC.